Greenlight Biosciences Holdings logo

Greenlight Biosciences Holdings Share Price Today (NASDAQ: GRNA)

Greenlight Biosciences Holdings share price is $0 & ₹0.00 as on 19 Jul 2023 IST

-0.3

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 20 Jul 2023

View live Greenlight Biosciences Holdings share price in Dollar and Rupees. Guide to invest in Greenlight Biosciences Holdings stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Greenlight Biosciences Holdings, along with analyst recommendations, forecasts, and comprehensive financials.

Greenlight Biosciences Holdings (GRNA) Key Statistics

in dollars & INR

Previous Close
$0.2995
Open
$0.2995
Market Capitalization
$45.0M
Today's Volume
$143.2K
Revenue TTM
$10.3M
EBITDA
$-146.2M
Earnings Per Share (EPS)
$-1.12
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-366.87%

How to invest in Greenlight Biosciences Holdings Stock (GRNA) from India?

It is very easy for Indian residents to invest directly in Greenlight Biosciences Holdings from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Greenlight Biosciences Holdings stock in both Indian Rupees (INR) and US Dollars (USD). Search for Greenlight Biosciences Holdings or GRNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Greenlight Biosciences Holdings or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Greenlight Biosciences Holdings shares which would translate to null fractional shares of Greenlight Biosciences Holdings as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Greenlight Biosciences Holdings, in just a few clicks!

Global Institutional Holdings in Greenlight Biosciences Holdings

  • Cormorant Asset Management, LLC

    6.06%

  • Continental Grain Co.

    4.28%

  • BlackRock Inc

    3.27%

  • Hudson Bay Capital Management LP

    2.33%

  • Tao Capital Management LP

    1.76%

  • Board of Ttees Leland Stanford Jr Univ

    1.11%

Analyst Recommendation on Greenlight Biosciences Holdings

Rating
Trend

Hold

    0%Buy

    57%Hold

    42%Sell

Based on 7 Wall street analysts offering stock ratings for Greenlight Biosciences Holdings(by analysts ranked 0 to 5 stars)

About Greenlight Biosciences Holdings

GreenLight Biosciences Holdings operates as a pre-commercial stage biotechnology company in the United States of America. It provides cell-free ribonucleic acid (RNA) production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company's plant and animal health pipeline includes Calantha for the Colorado potato beetle; Varroa mites, an RNA-based syrup that targets reproductive mites; Vegetable Caterpillar Complex, an dsRNA-based pesticide for the Diamond Back Moth; and Spider Mite Complex for the control of Tetranychus urticae. It also developing fungicides program for botrytis, fusarium, powdery mildew, downy mildew, Asian soybean rust, and rice blast; Gray Mold + for botrytis cinerea; Powdery mildew complex for the control of powdery mildew, caused by Erysiphe necator; and Mycotoxin control for Fusarium Head Blight, a cereal crop based diseases. In addition, the company also developing human health program comprising a phase I/II preclinical stage vaccine for COVID-19; and candidate selection vaccines for Shingles, and oncology. GreenLight Biosciences Holdings was formerly known as Environmental Impact Acquisition Corp. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
Organization
Greenlight Biosciences Holdings
Employees
0
CEO
Dr. Andrey Juan Zarur Ph.D.
Industry
Miscellaneous

Important FAQs about investing in GRNA Stock from India :

Can Indians buy Greenlight Biosciences Holdings shares?

Yes, Indians can invest in the Greenlight Biosciences Holdings (GRNA) from India.

With INDmoney, you can buy Greenlight Biosciences Holdings at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Greenlight Biosciences Holdings at zero transaction cost.

How can I buy Greenlight Biosciences Holdings shares from India?

It is very easy to buy Greenlight Biosciences Holdings from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Greenlight Biosciences Holdings (GRNA) be purchased?

Yes, you can buy fractional shares of Greenlight Biosciences Holdings with INDmoney app.

What are the documents required to start investing in Greenlight Biosciences Holdings stocks?

To start investing in Greenlight Biosciences Holdings, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Greenlight Biosciences Holdings?

Today's market capitalisation of Greenlight Biosciences Holdings GRNA is 45.0M

Who is the Chief Executive Officer (CEO) of Greenlight Biosciences Holdings ?

Dr. Andrey Juan Zarur Ph.D. is the current Chief Executive Officer (CEO) of Greenlight Biosciences Holdings.